ATLANTA, GA – – (Globe Newswire – December 19, 2024) – – A shareholder class action lawsuit has been filed against Dentsply Sirona Inc. (“Dentsply” or “the Company”) (NASDAQ: XRAY). The lawsuit alleges that Defendants made materially false or misleading statements and/or concealed material adverse facts about Dentsply’s business, operations, and prospects, including allegations that: (1) Dentsply targeted low-income people who did not have access to good oral hygiene education, a dentist, or dental insurance, which often meant patients signing up for Byte had underlying dental issues that would have made them ineligible for treatment; (2) the push for Byte growth and sales commissions caused sales employees to sell to contraindicated patients; (3) as a result, the Byte patient onboarding workflow did not provide adequate assurance that contraindicated patients did not enter treatment; (4) before and during the Class Period, reports of Byte patient injuries were pouring in; (5) Dentsply knew that its Byte aligners were causing severe patient injuries for years but did little to investigate those injuries or notify the FDA; (6) Dentsply had no systems in place to notify the FDA of these injuries, which the Company is required to do within 30 days of learning of a problem; (7) the FDA had received a sharp uptick in reports of serious injuries from Byte patients; and (8) as a result of the above, Dentsply materially overstated the goodwill value of Byte.

If you bought shares of Dentsply between February 28, 2022 and November 6, 2024, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/dentsply-sirona/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is January 27, 2025.